{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:33:06Z","timestamp":1793395986082,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119317","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:37:49Z","timestamp":1789688269000},"page":"119317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies"],"prefix":"10.1016","volume":"320","author":[{"given":"Sri Mounika","family":"Bellapukonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Akanksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mainak","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Bandela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Kodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhendu","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxma Naik","family":"Korra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-8694","authenticated-orcid":false,"given":"Venkata Madhavi","family":"Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119317_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/17568919.2025.2525069","article-title":"Exploration of pyrazole-based pyridine-4-carbohydrazide derivatives as drug-resistant Mtb agents: design, synthesis, biological evaluation, and in-silico studies","volume":"17","author":"Kumar","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70074","article-title":"Exploration of new dihydroindazole derivatives as promising Anti\u2010TB agents: design, synthesis, in Silico, and biological evaluation","volume":"358","author":"Kumar","year":"2025","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119317_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130601","article-title":"Structure\u2013activity relationship\u2013driven lead optimization of pyrazole hydrazide\u2013hydrazone analogues as potent antimycobacterial agents: in vitro and in silico studies","volume":"136","author":"Kumar","year":"2026","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119317_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108447","article-title":"Exploring spirocyclic isoquinoline-piperidine compounds in tuberculosis therapy: ADMET profiling, docking, DFT, MD simulations, and MMGBSA analysis","volume":"118","author":"Bellapukonda","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400902","article-title":"Design, synthesis and biological evaluation of Ethyl 5\u2010(1\u2010benzyl\u20101 H \u2010indol\u20105\u2010yl) Isoxazole\u20103\u2010Carboxylates as antimycobacterial agents","volume":"20","author":"Bandela","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119317_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/17568919.2025.2479413","article-title":"Spirocyclic compounds: potential drug leads in the fight against Mycobacterium tuberculosis","volume":"17","author":"Kumar","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500633","article-title":"Exploration of new pyrazole\u2013hydrazone\u2013benzenesulfonamide conjugates as potent mycobacterial carbonic anhydrase inhibitors: design, synthesis, and biological evaluation","volume":"20","author":"Kumar","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119317_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109716","article-title":"Exploration of 1,3-di substituted pyrazole conjugates as DNA gyrase inhibitors to combat Staphylococcus aureus and Mycobacterium tuberculosis","volume":"174","author":"Bellapukonda","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib9","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1039\/D5MD00744E","article-title":"Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis \u03b2-carbonic anhydrases","volume":"16","author":"Bandela","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1080\/17568919.2025.2552642","article-title":"Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors","volume":"17","author":"Kumar","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib11","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1021\/acs.jmedchem.5c01026","article-title":"Exploring indole-linked triazole sulfonamide derivatives as potent mycobacterial carbonic anhydrase inhibitors: leveraging a tail approach for the design, synthesis, and In Silico studies\u2500an In-Depth multidisciplinary Study","volume":"68","author":"Singampalli","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106591","article-title":"Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis","volume":"138","author":"Khalifa","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107250","article-title":"Unlocking InhA: novel approaches to inhibit Mycobacterium tuberculosis","volume":"146","author":"Wahan","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107705","article-title":"Identification of antimycobacterial 8-hydroxyquinoline derivatives as in vitro enzymatic inhibitors of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase","volume":"151","author":"Joaquim","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107511","article-title":"New coumarin linked thiazole derivatives as antimycobacterial agents: design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling","volume":"150","author":"Kassem","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tube.2017.09.003","article-title":"Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA","volume":"107","author":"McNeil","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2026.119317_bib17","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1039\/D5MD00497G","article-title":"Therapeutic potential of spiro compounds against Staphylococcus aureus : a comprehensive review","volume":"16","author":"Kumar","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib18","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1039\/D5MD00336A","article-title":"Indazole \u2013 an emerging privileged scaffold: synthesis and its biological significance","volume":"16","author":"Singampalli","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117472","article-title":"A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives","volume":"289","author":"Bellapukonda","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500345","article-title":"Exploration of Benzofuran\/Indole\u2010Chalcone conjugated 1,2,3\u2010Triazole hybrids as Candida glabrata agents: design, synthesis, biological evaluation, molecular docking, and in Silico ADMET analysis","volume":"22","author":"Singampalli","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119317_bib21","first-page":"1","article-title":"A comprehensive review of indole hybrids as anti-bacterial and anti-fungal agents: synthetic protocols and SAR studies","author":"Bellapukonda","year":"2026","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130177","article-title":"Exploration of quinoxaline triazoles as antimycobacterial agents: design, synthesis and biological evaluation","volume":"121","author":"Kumar","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119317_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103955","article-title":"Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents","volume":"100","author":"Srinivasarao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105370","article-title":"Discovery of potent antitubercular agents: design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues","volume":"82","author":"Nandikolla","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2026.119317_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill Mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119317_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1080\/17568919.2024.2379240","article-title":"Synthesis of indole-functionalized isoniazid conjugates with potent antimycobacterial and antioxidant efficacy","volume":"16","author":"Gavadia","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s43094-025-00861-z","article-title":"Synthesis and biological evaluation of N-substituted indole chalcone derivatives as potent antitubercular agents","volume":"11","author":"Joshi","year":"2025","journal-title":"Future J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119317_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117562","article-title":"Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: design, synthesis, in vitro biological evaluation, molecular docking and ADME studies","volume":"98","author":"Reddyrajula","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib29","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.bmcl.2015.07.057","article-title":"Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents","volume":"25","author":"Kamal","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119317_bib30","article-title":"Synthesis of novel 4,5\u2010dihydropyrrolo[1,2\u2010 a ]quinoxalines, pyrrolo[1,2\u2010 a ]quinoxalin]\u20102\u2010ones and their antituberculosis and anticancer activity","volume":"353","author":"Makane","year":"2020","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119317_bib31","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.bmcl.2009.04.029","article-title":"A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles","volume":"19","author":"Karthikeyan","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119317_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2174\/1570178612666150924000909","article-title":"Synthesis of an indoloquinoxaline derivative as potential inhibitor of InhA enzyme of Mycobacterium tuberculosis","volume":"12","author":"Zanzoul","year":"2015","journal-title":"LOC"},{"key":"10.1016\/j.ejmech.2026.119317_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00938-18","article-title":"Rational design of biosafety level 2-Approved, multidrug-resistant strains of Mycobacterium tuberculosis through nutrient auxotrophy","volume":"9","author":"Vilch\u00e8ze","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119317_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400064","article-title":"Exploring rhodanine linked enamine\u2013carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: design, synthesis, biological evaluation, and molecular docking studies","volume":"357","author":"Maddipatla","year":"2024","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119317_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300309","article-title":"Exploration of 3\u2010aryl pyrazole\u2010tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors","volume":"356","author":"Ommi","year":"2023","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119317_bib36","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1021\/jo049056s","article-title":"Ortho-Selective nucleophilic aromatic substitution reactions of polyhaloanilines with Potassium\/Sodium O -Ethyl xanthate: a convenient access to halogenated 2(3 H)-Benzothiazolethiones","volume":"69","author":"Zhu","year":"2004","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib37","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of clofazimine by mycobacterial type 2 NADH:Quinone oxidoreductase","volume":"286","author":"Yano","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib38","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1099\/jmm.0.033167-0","article-title":"Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus","volume":"60","author":"Mirza","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119317_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400320","article-title":"Small peptide conjugates of Benzothiazole\u20102\u2010Carboxylic acids targeting DprE1 against tuberculosis","volume":"9","author":"Samoon","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119317_bib40","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1021\/acsinfecdis.4c00710","article-title":"2-Aryl-Benzoimidazoles as type II NADH dehydrogenase inhibitors of Mycobacterium tuberculosis","volume":"10","author":"Saha","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119317_bib41","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acsinfecdis.4c00415","article-title":"Development and evaluation of bis-benzothiazoles as a new class of benzothiazoles targeting DprE1 as antitubercular agents","volume":"10","author":"Samoon","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119317_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00036-21","article-title":"Transcription repressor protein ZBTB25 associates with HDAC1-Sin3a complex in mycobacterium tuberculosis-infected macrophages, and its inhibition clears pathogen by autophagy","volume":"6","author":"Madhavan","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2026.119317_bib43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119317_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177923","article-title":"Fully automated antibody structure prediction using BIOVIA tools: validation study","volume":"12","author":"Kemmish","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119317_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118154","article-title":"Synthesis and antibacterial evaluation of 5-(3-nitrophenyl)-N\u2032-arylisoxazole-3-carbohydrazide derivatives against carbapenem-resistant Acinetobacter baumannii","volume":"300","author":"Bandela","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119317_bib46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11094-025-03467-0","article-title":"Investigating the bioactivity of 1,5-Benzodiazepine derivatives: synthesis, characterization, molecular docking, and antimicrobial evaluation","volume":"59","author":"Chagaleti","year":"2025","journal-title":"Pharm. Chem. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:28:14Z","timestamp":1792643294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0223523426007622"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119317","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119317"}}